California Depakote Birth Defect Lawyers for Children Born With Neural Tube Defects, Defects of the Brain and Spinal Cord, Spina Bifida, and other Major Birth Defects, such as and Cardiovascular Malformations, as Craniofacial Defects, Limb Defects from Use of Antiepileptic Drugs, Depakote, Depokene, Depocon, Stavzor, Volporic Acid, During Pregnancy, Serving Los Angeles County and the San Francisco Bay Area, in Southern California from San Diego to Riverside San Bernardino Orange County Los Angeles Ventura Santa Barbara and Fresno, and in Northern California in the San Francisco Bay Area Oakland Santa Clara County San Jose and Sacramento.

If your child has suffered a birth defect following use of Depakote, Depokene Depocon, Stavzor, Vorporic Acid or another antiepileptic drug during pregnancy, our California Depakote birth defect lawyers welcome you to contact us for a free consultation. Our California Depakote birth defect attorneys will consider cases involving neural tube birth defects, defects of the brain and spinal cord, such as spina bifida, as well as other major birth defects, such as craniofacial defects, malformed face and skull, brachycephaly, cardiovascular defects, including coarctation of the aorta, atrial septal defects,hypoplastic right heart, hydronephrosis, distension and dilation of the renal pelvis, cleft palate, dysplatic ribs, undescended testes, hypospadia, hand malformations, and hepatic failure leading to the death of the infant. Our California Depakote birth defect lawyers serve all of Northern and Southern California from San Diego to Sacramento, from Riverside and San Bernardino to Orange County, Los Angeles, Santa Barbara and Fresno to the San Francisco Bay Area, Oakland, Berkeley, San Jose, Santa Clara County and Sacramento.

If your child has suffered a birth defect following a pregnancy in which Depakote or another antiseizure medication (often prescribed also for migraine headaches and bipolar disease), you are invited to contact our California Depakote birth defect lawyers. Simply fill out our Contact form and one of our pharmaceutical product liability attorneys will promptly call you to discuss your case, offer his initial case evaluation and preliminary recommendations. Our Depakote birth defect lawyers serve all of California, in Southern California from San Diego, San Bernardino and Riverside to Orange County and Los Angeles, Ventura to Central California, Fresno and Northern California, from San Jose and Santa Clara County to the San Francisco Bay Area, Berkeley and Oakland up to Sacramento.

Our Depakote Birth Defect Lawyers Consider That The Scientific Evidence Is Sufficient to Demonstrate Far Greater Than a Doubling in the Incidence of Many Major Birth Defects Including Neural Tube Defects Involving the Spinal Cord and Brain, Such As Spina Bifida, Craniofacial Defects, as Well As Cardiovascular Malformations, Leading Us to Consider that the Depakote Lawsuits Will be Successful Particularly in Birth Defect Cases Involving the Mother's Use of Depakote, Depokene, Depocon, Stravzor, Vorporic Acid and Other Antiepileptic Drugs During the First Trimester of Pregnancy.

Our California Depakote lawyers have accumulated the evidence from epidemiological studies comparing the incidence of most major birth defects in populations of newborns exposed to Depakote and other similar seizure drugs (AEDs) during early organogenisis, as well as data from the North American Antiepleptic Drug Pregnancy Registry, and from the FDA, and we consider that there is greater than a doubling in incidence of many major birth defects. For neural tube defects the increased incidence has been reported from 10 times to 30 and as high as 80 times the incidence in the general population. Pharmaceutical product liability lawyers commonly consider as one of the criteria for drug product liability litigation whether there is a "doubling" in the side effect incidence because the burden of proof in the litigation is to demonstrate that the child's birth defect occurred "more likely than not" from exposure to the drug. "Causation," however, cannot credibly be disputed by the drug manufacturer when there is overwhelming scientific evidence of a 10 fold increased incidence, let alone a 30 fold or 80 fold increased incidence of the particular defect in the population of infants born after first trimester exposure to the drug in utero.

The United States Food and Drug Administration Has Determined that Maternal Use of Depakote During the First Trimester of Pregnancy is Associated with an Increased Risk of Birth Defects, Adding to our Depakote Side Effect Lawyers' Confidence that the Increase in Neural Tube Defects, Brain and Spinal Cord Defects including Spina Bifida as Well as Other Major Birth Defects, such as Craniofacial Defects, Abnormally Formed Face, Cleft Palate, and Skull Enclosing the Brain, and Cariovascular and Heart Malformations as well as Limb Defects and Skeletal Anomalies Result from Maternal Use of Depakote During the First 12 Weeks of Pregnancy.

The United States Food and Drug Administration first approved Depakene (valporate acid) for the treatment of epilepsy, and then subsequently approved valporic acid, also marketed as Stravzor, and Divalprox sodium, marketed as Depakote, Depakote CHP, Depakote ER for the treatment of migraine headaches and bipolar disease. However, the FDA has subsequently determined that these drugs, which we will describe here generally as "Depakote" are teratogenic if taken during the first trimester of pregnancy.

More specifically, the FDA has confirmed that there is an increased risk of neural tube defects, meaning defects of the brain or spinal cord, such as spina bifida, as well as other major birth defects such as craniofacial defects, meaning abnormally formed face and skull, such as cleft palate, cardiovascular defects, including serious heart anomalies and defects in blood vessels, and skeletal anomalies, including limb reduction defects.

Our Depakote Birth Defect Lawyers Will Consider Cases Involving the The Breadth of Depakote Related Birth Defects Throughout the State of California, from San Diego to Sacramento, from Los Angeles to the San Francisco Bay Area, from San Bernardino and Riverside to Orange County, Fresno, San Jose, Santa Clara County, Berkeley and Oakland.

The list of birth defects that can result of maternal use of Depakote during the first 12 weeks of pregnancy is extensive and not limited to those that have been identified by example above. Additional specific birth defects associated with Depakote use include coarctation of the aorta, atrial septal defects, hydronephrosis, cleft palate, dysplastic ribs, pulmonary stenosis, hand malformations, undescended testes, hypospadias, hypoplastic right heart, neural tube defects. Depakote can also result in hepatic failure sometimes leading to deaths of newborns and infants. Depakote can also result in poor growth, developmental delays, short and broad noses, small teeth and small head, as well as a variety of limb anomalies including shortened limbs and hand malformations.

Our California Depakote birth defect attorneys invite any parent whose child has suffered a birth anomaly to contact us for a free consultation. Our Depakote birth defect lawyers will consider cases arising throughout the state of California, from San Diego, Riverside and San Bernardino to Orange County and Los Angeles, from Ventura to Fresno, San Jose and Santa Clara County, the San Francisco Bay Area, Berkeley and Oakland up to Sacramento. You may submit the Contact form and one of our California Depakote lawyers will call you to discuss your case and offer his initial case evaluation and preliminary recommendations. Our initial case consultations are free of charge and without obligation.